The five largest pharmaceutical companies in the United States netted approximately $81.9 billion last year, according to a new report by Accountable.us, a non-profit organization that documents the activities of special interest groups. Accountable.us compiled Securities and Exchanges Commission (SEC) filings and other financial disclosures from Pfizer, Johnson & Johnson, Merck, AbbVie and Eli Lilly. […]
Merck & Co. filed a lawsuit against the U.S. government on June 6, saying that Medicare’s new program, established under the Inflation Reduction Act (IRA), is a “sham” that violates the First and Fifth Amendments of the U.S. Constitution. President Joe Biden signed the IRA into law in August of last year, allowing Medicare to […]
A widely used COVID-19 treatment drug could be linked to mutations that create new variants of the disease, according to researchers in a new pre-print study. Published in Medxriv (pdf), researchers cited an analysis of more than 13 million viral genomes in worldwide databases and found that the drug Lagevrio, also known as molnupiravir, that there were mutations […]
Dozens of lawsuits against Merck & Co. allege plaintiffs suffer severe side effects after taking the HPV vaccine. The United States Judicial Panel on Multidistrict Litigation issued an order on Aug. 4, consolidating over 30 cases so they’ll be heard by the same judge. Lawyer Robert F. Kennedy Jr. is representing some of the plaintiffs in the […]
After several months of legal back-and-forth in the courtroom, with the FDA requesting up to 75 years to release all of their vaccine safety-related documents, a federal court has just ruled against them. Instead, that judge said the FDA has only eight months to release all of their Pfizer vaccine safety data—meaning that we might […]
The FDA is authorizing a second pill to treat COVID-19. How effective is it and who can get it? One Chinese city that’s larger than the Big Apple is again under tight lockdown, after reporting over a hundred CCP (Chinese Communist Party) virus cases. How strict are the measures and how are people reacting to it? A senator details […]
The Food and Drug Administration (FDA) on Thursday morning issued an emergency use authorization for Merck’s antiviral pill for COVID-19, more than 12 hours after giving the green light for a similar, oral drug made by Pfizer. Merck’s drug, named molnupiravir, was developed with Ridgeback Biotherapeutics, and it was shown to reduce hospitalizations and deaths from […]
Denmark on Thursday approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients with symptoms, including the elderly. The Scandinavian country became the first in the European Union to approve the antiviral treatment called molnupiravir. The pill is still under review by the European Medicines Agency (EMA). “We are recommending the pill […]
Outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday narrowly voted to recommend the agency grant emergency use authorization (EUA) for a drug from Merck and Ridgeback Biotherapeutics to treat COVID-19, called molnupiravir. Members of the FDA’s Antimicrobial Drugs Advisory Committee voted 13 for and 10 against the EUA for molnupiravir, agreeing with […]
A new analysis of clinical trial results shows that Merck’s antiviral pill for treating COVID-19 is significantly less effective than previously reported in October, the company announced on Friday. In the updated report, the drugmaker said its antiviral treatment drug, which is called molnupiravir, showed a 30 percent reduction in hospitalizations and deaths from the […]
Britain’s medicines regulator has given a green light on Thursday to an antiviral COVID-19 pill jointly developed by U.S.-based Merck and partner Ridgeback Biotherapeutics. The drug, known as molnupiravir, has been recommended by Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) to be used during the early stages of infection, within five days of the onset of symptoms, […]
AMSTERDAM—The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, the first pill that has been shown to treat the disease. In a statement on Monday, Merck said the EU drug regulator had started an expedited licensing process for molnupiravir. If given the green light, it would […]
The Bill & Melinda Gates Foundation will fund up to $120 million worth of an experimental drug that is used in treating COVID-19 to assist lower-income countries in its CCP virus response if the drug gets approved, the foundation announced on Tuesday.
A new COVID-19 pill that can purportedly cut the risk of both hospitalization as well as death from COVID-19—by as much as 50 percent—is now in the process of getting emergency use authorization. However, according to several researchers, the technology that this pill uses runs the risk of potentially causing cancer, although, according to one […]
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as it costs a fraction of that to produce, and is reportedly on track for a price of $12 in India. The gap between production costs and the price for molnupiravir is gigantic and emblematic of a problem […]
Merck and its partner on Monday announced they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral medicine for the treatment of COVID-19. The pill is meant to combat cases of mild or moderate COVID-19. Merck said last week that an interim analysis of its phase […]
Results from a clinical trial show that Merck’s antiviral pill for COVID-19 is effective, the company said Friday. The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial. Compared to the 14.1 percent of […]
